HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eleven have given a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $110.5714.

HQY has been the subject of a number of research analyst reports. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research note on Monday, June 1st. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 15,551 shares of company stock worth $1,427,650 in the last 90 days. 1.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently modified their holdings of the stock. Capricorn Fund Managers Ltd bought a new position in HealthEquity during the fourth quarter valued at about $6,926,000. Congress Asset Management Co. raised its position in HealthEquity by 36.3% in the fourth quarter. Congress Asset Management Co. now owns 101,816 shares of the company’s stock worth $9,327,000 after acquiring an additional 27,102 shares in the last quarter. Oxbow Advisors LLC acquired a new stake in HealthEquity in the 1st quarter valued at about $3,147,000. Westfield Capital Management Co. LP boosted its position in shares of HealthEquity by 13.7% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after purchasing an additional 235,794 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd bought a new position in shares of HealthEquity during the 4th quarter valued at about $4,381,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Price Performance

NASDAQ:HQY opened at $94.73 on Thursday. The firm has a market cap of $7.92 billion, a price-to-earnings ratio of 35.48, a price-to-earnings-growth ratio of 1.63 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity has a 12-month low of $72.76 and a 12-month high of $105.96. The company’s 50-day moving average is $86.93 and its two-hundred day moving average is $84.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity will post 3.92 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.